ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Erratum to: Switching to bictegravir/emtricitabine/tenofovir alafenamide maintained HIV-1 RNA suppression in participants with archived antiretroviral resistance including M184V/I
Journal of Antimicrobial Chemotherapy
◽
10.1093/jac/dkz412
◽
2019
◽
Vol 74
(12)
◽
pp. 3646-3647
Author(s):
Kristen Andreatta
◽
Madeleine Willkom
◽
Ross Martin
◽
Silvia Chang
◽
Lilian Wei
◽
...
Keyword(s):
Antiretroviral Resistance
◽
Tenofovir Alafenamide
◽
Hiv 1
Download Full-text
Related Documents
Cited By
References
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed
Case Medical Research
◽
10.31525/ct1-nct04132674
◽
2019
◽
Author(s):
Keyword(s):
Fixed Dose Combination
◽
Fixed Dose
◽
Marginalized Populations
◽
Dose Combination
◽
Tenofovir Alafenamide
◽
Hiv 1
Download Full-text
P21 Prevalence of antiretroviral resistance mutations in treatment-naive HIV-1-infected patients in South London
HIV Medicine
◽
10.1046/j.1468-1293.2000.00024-89.x
◽
2000
◽
Vol 1
(3)
◽
pp. 179-179
Author(s):
Am Geretti
◽
M Smith
◽
M Donati
◽
P Easterbrook
◽
M Zuckerman
Keyword(s):
Resistance Mutations
◽
Antiretroviral Resistance
◽
Treatment Naïve
◽
Hiv 1
Download Full-text
Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV‐1‐infected patients: a real‐world study in Japan
HIV Medicine
◽
10.1111/hiv.13061
◽
2021
◽
Author(s):
Naoki Kanda
◽
Koh Okamoto
◽
Hisatoshi Okumura
◽
Makiko Mieno
◽
Kentaro Sakashita
◽
...
Keyword(s):
Real World
◽
Tenofovir Disoproxil Fumarate
◽
Treatment Change
◽
Tenofovir Alafenamide
◽
Hiv 1
Download Full-text
Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads
Journal of Antimicrobial Chemotherapy
◽
10.1093/jac/dky316
◽
2018
◽
Vol 73
(11)
◽
pp. 3129-3136
◽
Cited By ~ 6
Author(s):
Narjis Boukli
◽
Anders Boyd
◽
Marianne Collot
◽
Jean-Luc Meynard
◽
Pierre-Marie Girard
◽
...
Keyword(s):
Viral Loads
◽
Hiv Rna
◽
Antiretroviral Resistance
◽
Hiv 1
Download Full-text
HIV-1 Antiretroviral Resistance
Drugs
◽
10.2165/11633630-000000000-00000
◽
2012
◽
Vol 72
(9)
◽
pp. e1-e25
◽
Cited By ~ 173
Author(s):
Michele W. Tang
◽
Robert W. Shafer
Keyword(s):
Antiretroviral Resistance
◽
Hiv 1
Download Full-text
Longer-Term Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide Versus Emtricitabine and Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Week 96 Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
SSRN Electronic Journal
◽
10.2139/ssrn.3772801
◽
2021
◽
Author(s):
Onyema Ogbuagu
◽
Peter J. Ruane
◽
Daniel Podzamczer
◽
Laura C. Salazar
◽
Keith Henry
◽
...
Keyword(s):
Tenofovir Disoproxil Fumarate
◽
Phase 3
◽
Double Blind
◽
Safety And Efficacy
◽
Double Blind Placebo
◽
Tenofovir Alafenamide
◽
Exposure Prophylaxis
◽
Hiv 1
Download Full-text
Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil
Virus Research
◽
10.1016/j.virusres.2005.10.004
◽
2006
◽
Vol 116
(1-2)
◽
pp. 201-207
◽
Cited By ~ 50
Author(s):
Rosangela Rodrigues
◽
Luciene C. Scherer
◽
Cristina M. Oliveira
◽
Heitor Moreira Franco
◽
Rosa Dea Sperhacke
◽
...
Keyword(s):
Newly Diagnosed
◽
Polymerase Gene
◽
Resistance Mutations
◽
Antiretroviral Resistance
◽
Clade C
◽
Low Prevalence
◽
Hiv 1
◽
South Brazil
Download Full-text
Impact of antiretroviral resistance and virological failure on HIV-1 informational entropy
Journal of Antimicrobial Chemotherapy
◽
10.1093/jac/dkx508
◽
2018
◽
Vol 73
(4)
◽
pp. 1054-1059
Author(s):
Elidamar Nunes de Carvalho Lima
◽
José Roberto Castilho Piqueira
◽
Michelle Camargo
◽
Juliana Galinskas
◽
Maria Cecilia Sucupira
◽
...
Keyword(s):
Virological Failure
◽
Informational Entropy
◽
Antiretroviral Resistance
◽
Hiv 1
Download Full-text
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
The Lancet
◽
10.1016/s0140-6736(17)32340-1
◽
2017
◽
Vol 390
(10107)
◽
pp. 2073-2082
◽
Cited By ~ 97
Author(s):
Paul E Sax
◽
Anton Pozniak
◽
M Luisa Montes
◽
Ellen Koenig
◽
Edwin DeJesus
◽
...
Keyword(s):
Initial Treatment
◽
Phase 3
◽
Double Blind
◽
Multicentre Phase
◽
Tenofovir Alafenamide
◽
Hiv 1
Download Full-text
Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients
AIDS
◽
10.1097/qad.0000000000002463
◽
2020
◽
Vol 34
(5)
◽
pp. 707-718
◽
Cited By ~ 4
Author(s):
Chloe Orkin
◽
Joseph J. Eron
◽
Jürgen Rockstroh
◽
Daniel Podzamczer
◽
Stefan Esser
◽
...
Keyword(s):
Phase 3
◽
Treatment Naïve
◽
Tenofovir Alafenamide
◽
Hiv 1
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close